Amylyx Pharmaceuticals, Inc. (AMLX)

SEC filing

Amylyx Pharmaceuticals, Inc.

AMLX · CIK 1658551

4 · Jan 20, 2026 · Cohen Joshua B sold 138.17K shares at $13.59/share ($1.9M); exercised options for 200K shares

Cohen Joshua B sold 138.17K shares at $13.59/share ($1.9M); exercised options for 200K shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.